Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

The Effect of Diagnostic Wait Time on the Survival of Patients with Diffuse Large B-Cell Lymphoma Differs Depending on International Prognostic Index

Shin Lee, MD, Negoro Eiju, Morishita Tetsuji, MD PhD, Kei Fujita, MD, Hideaki Yamauchi, MD, Kana Oiwa, MD, Takanori Ueda, MD PhD, Takahiro Yamauchi, MD PhD

Blood (2019) 134 (Supplement_1): 2902.

https://doi.org/10.1182/blood-2019-121527

Published: 2019

Journal Articles

Econsultation to Hematologists from Primary Care: An Assessment of Content and Patient Impact

Megan Leslie, BS, Sa Ra Park, MD, Jennifer Wang, MD, Kelly Mercer Davidson, MD, Kimberly Dowdell, MD

Blood (2018) 132 (Supplement 1): 2279.

https://doi.org/10.1182/blood-2018-99-114149

Published: 2018

Journal Articles

Preclinical Development of CTX120, an Allogeneic CAR-T Cell Targeting Bcma

Henia Dar, Daniel Henderson, Zinkal Padalia, MS, Ashley Porras, Dakai Mu, MS, Maeng Kyungah, PhD, Seshidhar Police, PhD, Demetrios Kalaitzidis, PhD, Jonathan Terrett, PhD, Jason Sagert, PhD

Blood (2018) 132 (Supplement 1): 1921.

https://doi.org/10.1182/blood-2018-99-116443

Published: 2018

Journal Articles

Impact of Wait Times for Autologous Stem Cell Transplantation in Patients with Aggressive Non-Hodgkin Lymphoma, a Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial

Tanya Skamene, MD, Wenyu Jiang, PhD, Ralph M. Meyer, MD, Michael Crump, MD, John Kuruvilla, MD, C. Tom Kouroukis, MD MSc, FRCPC, Stefano Luminari, Stephen Couban, MD, Matthew C. Cheung, MD SM, FRCPC, David A Rizzieri, MD, Peter G Bardy, MBBS, FRACP, FRCPA, Joseph Pater, MD MSc, Marina S. Djurfeldt, MSc, Lois E. Shepherd, MD, Bingshu E Chen, PhD, Annette E Hay, MB ChB

Blood (2016) 128 (22): 690.

https://doi.org/10.1182/blood.V128.22.690.690

Published: 2016

Journal Articles

Wait Times and Bed Capacity for Hematopoietic Cell Transplantation in Ontario: A System Dynamics Model

Jonathan Wang, MASc, Saba Vahid, PhD, Hertz Sherrie, BScPhm, C. Tom Kouroukis, MD MSc, FRCPC

Blood (2016) 128 (22): 2378.

https://doi.org/10.1182/blood.V128.22.2378.2378

Published: 2016

Journal Articles

Patient-Reported Experiences with Treatment of Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL): Results of a Quantitative Survey

Brad Schenkel, MSc, Ahmad B. Naim, MD, Barbara Roland, MBA, Susan Wyant, PharmD

Blood (2014) 124 (21): 5442.

https://doi.org/10.1182/blood.V124.21.5442.5442

Published: 2014

Journal Articles

Barriers To Diagnosis In Myeloproliferative Neoplasms

Raymond H L Yip, Lynda M Foltz, MD, FRCP(C)

Blood (2013) 122 (21): 5248.

https://doi.org/10.1182/blood.V122.21.5248.5248

Published: 2013

Journal Articles

Who Participates in an Adult Cooperative Group Trial for Adolescent and Young Adults (AYAs)? Baseline Demographic and Psychosocial Characteristics of AYAs Enrolled On Intergroup Trial C10403 for Acute Lymphoblastic Leukemia (ALL)

Lori S. Muffly, MD, Wendy Stock, MD, Kate Breitenbach, APN, Flora Mulkey, Selina Luger, MD, Anjali Advani, MD, Edy Parker, Matthew C Foster, MD, Michaela Liedtke, MD, Reynaldo Garcia, RN, Kristin Coffan, Joselene Sipin-Sayno, Jennifer McNeer, MD, MS, Martin S Tallman, MD, Frederick R. Appelbaum, MD, Richard M. Stone, MD, Richard A. Larson, MD

Blood (2012) 120 (21): 3535.

https://doi.org/10.1182/blood.V120.21.3535.3535

Published: 2012

Journal Articles

Do Sickle Cell Patients Wait Longer to See Physicians in the Emergency Department?

Carlton Haywood, Jr., PhD, MA, Rakhi Naik, MD, Mary Catherine Beach, MD, MPH, Sophie Lanzkron, MD, MHS

Blood (2011) 118 (21): 2070.

https://doi.org/10.1182/blood.V118.21.2070.2070

Published: 2011

Journal Articles

Results of the AIEOP-BFM ALL 2000 Study for Childhood Acute Lymphoblastic Leukemia IN AIEOP High Risk Patients.

Valentino Conter, MD, Maria Grazia Valsecchi, PhD, Maurizio Aricò, Carmelo Rizzari, Rosanna Parasole, Chiara Messina, Giulio De Rossi, Elena Barisone, Luca Lo Nigro, Nicola Santoro, Ottavio Ziino, Franco Locatelli, Andrea Pession, Anna Maria Testi, Concetta Micalizzi, Andrea Biondi, Giuseppe Basso, Daniela Silvestri, Giuseppe Masera, MD

Blood (2009) 114 (22): 319.

https://doi.org/10.1182/blood.V114.22.319.319

Published: 2009

NARROW

The Effect of Diagnostic Wait Time on the Survival of Patients with Diffuse Large B-Cell Lymphoma Differs Depending on International Prognostic Index

Econsultation to Hematologists from Primary Care: An Assessment of Content and Patient Impact

Preclinical Development of CTX120, an Allogeneic CAR-T Cell Targeting Bcma

Impact of Wait Times for Autologous Stem Cell Transplantation in Patients with Aggressive Non-Hodgkin Lymphoma, a Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial

Wait Times and Bed Capacity for Hematopoietic Cell Transplantation in Ontario: A System Dynamics Model

Patient-Reported Experiences with Treatment of Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL): Results of a Quantitative Survey

Barriers To Diagnosis In Myeloproliferative Neoplasms

Who Participates in an Adult Cooperative Group Trial for Adolescent and Young Adults (AYAs)? Baseline Demographic and Psychosocial Characteristics of AYAs Enrolled On Intergroup Trial C10403 for Acute Lymphoblastic Leukemia (ALL)

Do Sickle Cell Patients Wait Longer to See Physicians in the Emergency Department?

Results of the AIEOP-BFM ALL 2000 Study for Childhood Acute Lymphoblastic Leukemia IN AIEOP High Risk Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only